Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer (Q44565471)

4 December 2017

title

Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer (English)

1 reference

4 December 2017

Bridget N Fahy

1 reference

4 December 2017

Michael G Schlieman

series ordinal

1 reference

4 December 2017

Subbulakshi Virudachalam

series ordinal

1 reference

4 December 2017

Richard J Bold

series ordinal

1 reference

4 December 2017

publication date

1 July 2003

1 reference

Journal of Surgical Research

4 December 2017

published in

1 reference

4 December 2017

volume

113

1 reference

4 December 2017

1 reference

4 December 2017

page(s)

88-95

1 reference

4 December 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Development of the proteasome inhibitor PS-341.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

The ubiquitin-proteasome proteolytic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

The ubiquitin-proteasome pathway in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Deadly encounter: ubiquitin meets apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Proteasome-dependent regulation of p21WAF1/CIP1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

An immunohistochemical analysis of p27 expression in human pancreatic carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Correlation between TGF-beta1 and p21 (WAF1/CIP1) expression and prognosis in resectable invasive ductal carcinoma of the pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Loss of p27Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Sequence-dependent cytotoxicity of etoposide and paclitaxel in human breast and lung cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Clonogenic cell assay for anchorage-dependent squamous carcinoma cell lines using limiting dilution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

In vitro preclinical models for a rational design of chemotherapy combinations in human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Proteasome inhibition: a new strategy in cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Interferon-alpha suppresses the antiapoptotic effect of NF-kB and sensitizes renal cell carcinoma cells in vitro to chemotherapeutic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Nuclear factor-kappa B is upregulated in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

NF-kappa B activation in topoisomerase I inhibitor-induced apoptotic cell death in human non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900201-4

10.1016/S0022-4804(03)00201-4

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference